Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) Research & Development (2016 - 2025)

Historic Research & Development for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $1.1 million.

  • Solesence's Research & Development rose 1154.64% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 1748.37%. This contributed to the annual value of $3.8 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Solesence reported Research & Development of $1.1 million as of Q3 2025, which was up 1154.64% from $955000.0 recorded in Q2 2025.
  • Over the past 5 years, Solesence's Research & Development peaked at $1.1 million during Q4 2024, and registered a low of $499000.0 during Q1 2021.
  • For the 5-year period, Solesence's Research & Development averaged around $842052.6, with its median value being $864000.0 (2024).
  • Examining YoY changes over the last 5 years, Solesence's Research & Development showed a top increase of 5679.01% in 2021 and a maximum decrease of 5990.06% in 2021.
  • Quarter analysis of 5 years shows Solesence's Research & Development stood at $565000.0 in 2021, then grew by 28.67% to $727000.0 in 2022, then grew by 7.98% to $785000.0 in 2023, then skyrocketed by 38.98% to $1.1 million in 2024, then fell by 0.82% to $1.1 million in 2025.
  • Its Research & Development was $1.1 million in Q3 2025, compared to $955000.0 in Q2 2025 and $1.0 million in Q1 2025.